241 related articles for article (PubMed ID: 38169973)
1. Applications of CRISPR screening to lung cancer treatment.
Shen W; Hu F; Lei P; Tang Y
Front Cell Dev Biol; 2023; 11():1295555. PubMed ID: 38169973
[TBL] [Abstract][Full Text] [Related]
2. A review on CRISPR/Cas: a versatile tool for cancer screening, diagnosis, and clinic treatment.
Yang X; Zhang B
Funct Integr Genomics; 2023 May; 23(2):182. PubMed ID: 37231285
[TBL] [Abstract][Full Text] [Related]
3. Effect of CRISPR/Cas9-Edited PD-1/PD-L1 on Tumor Immunity and Immunotherapy.
Xu Y; Chen C; Guo Y; Hu S; Sun Z
Front Immunol; 2022; 13():848327. PubMed ID: 35300341
[TBL] [Abstract][Full Text] [Related]
4. [Functional genetic screening using CRISPR-Cas9 system].
Li H; Huang C
Sheng Wu Gong Cheng Xue Bao; 2018 Apr; 34(4):461-472. PubMed ID: 29701021
[TBL] [Abstract][Full Text] [Related]
5. CRISPR-Cas9, A Promising Therapeutic Tool for Cancer Therapy: A Review.
Akram F; Ikram Ul Haq ; Ahmed Z; Khan H; Ali MS
Protein Pept Lett; 2020; 27(10):931-944. PubMed ID: 32264803
[TBL] [Abstract][Full Text] [Related]
6. CRISPR/Cas9 as precision and high-throughput genetic engineering tools in gastrointestinal cancer research and therapy.
Hosseini SA; Salehifard Jouneghani A; Ghatrehsamani M; Yaghoobi H; Elahian F; Mirzaei SA
Int J Biol Macromol; 2022 Dec; 223(Pt A):732-754. PubMed ID: 36372102
[TBL] [Abstract][Full Text] [Related]
7. The Application of CRISPR/Cas9 Technology for Cancer Immunotherapy: Current Status and Problems.
Wang L; Chen Y; Liu X; Li Z; Dai X
Front Oncol; 2021; 11():704999. PubMed ID: 35111663
[TBL] [Abstract][Full Text] [Related]
8. Progress on genome-wide CRISPR/Cas9 screening for functional genes and regulatory elements.
Liu SY; Yi GQ; Tang ZL; Chen B
Yi Chuan; 2020 May; 42(5):435-443. PubMed ID: 32431295
[TBL] [Abstract][Full Text] [Related]
9. Recent advances and applications of CRISPR-Cas9 in cancer immunotherapy.
Liu Z; Shi M; Ren Y; Xu H; Weng S; Ning W; Ge X; Liu L; Guo C; Duo M; Li L; Li J; Han X
Mol Cancer; 2023 Feb; 22(1):35. PubMed ID: 36797756
[TBL] [Abstract][Full Text] [Related]
10. Review of applications of CRISPR-Cas9 gene-editing technology in cancer research.
Zhao Z; Li C; Tong F; Deng J; Huang G; Sang Y
Biol Proced Online; 2021 Jul; 23(1):14. PubMed ID: 34261433
[TBL] [Abstract][Full Text] [Related]
11. Evolution of Molecular Targeted Cancer Therapy: Mechanisms of Drug Resistance and Novel Opportunities Identified by CRISPR-Cas9 Screening.
Hou J; He Z; Liu T; Chen D; Wang B; Wen Q; Zheng X
Front Oncol; 2022; 12():755053. PubMed ID: 35372044
[TBL] [Abstract][Full Text] [Related]
12. Applications of CRISPR/Cas9 Technology in the Treatment of Lung Cancer.
Jiang C; Lin X; Zhao Z
Trends Mol Med; 2019 Nov; 25(11):1039-1049. PubMed ID: 31422862
[TBL] [Abstract][Full Text] [Related]
13. A quantitative and multiplexed approach to uncover the fitness landscape of tumor suppression in vivo.
Rogers ZN; McFarland CD; Winters IP; Naranjo S; Chuang CH; Petrov D; Winslow MM
Nat Methods; 2017 Jul; 14(7):737-742. PubMed ID: 28530655
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic status and the prospect of CRISPR/Cas9 gene editing in multiple myeloma.
Hong L; Zhang C; Jiang Y; Liu H; Huang H; Guo D
Future Oncol; 2020 Jun; 16(16):1125-1136. PubMed ID: 32338048
[TBL] [Abstract][Full Text] [Related]
15. CRISPR-cas9: a powerful tool towards precision medicine in cancer treatment.
Xing H; Meng LH
Acta Pharmacol Sin; 2020 May; 41(5):583-587. PubMed ID: 31792341
[TBL] [Abstract][Full Text] [Related]
16. CRISPR/Cas9 gene editing: a new approach for overcoming drug resistance in cancer.
Vaghari-Tabari M; Hassanpour P; Sadeghsoltani F; Malakoti F; Alemi F; Qujeq D; Asemi Z; Yousefi B
Cell Mol Biol Lett; 2022 Jun; 27(1):49. PubMed ID: 35715750
[TBL] [Abstract][Full Text] [Related]
17. CRISPR-dCas9-Based Artificial Transcription Factors to Improve Efficacy of Cancer Treatment With Drug Repurposing: Proposal for Future Research.
Martinez-Escobar A; Luna-Callejas B; Ramón-Gallegos E
Front Oncol; 2020; 10():604948. PubMed ID: 33614489
[TBL] [Abstract][Full Text] [Related]
18. [Development and applications of CRISPR/Cas9 library screening technology in cancer research].
Lei T; Xiao B; He Y; Qu J; Sun Z; Li L
Nan Fang Yi Ke Da Xue Xue Bao; 2019 Nov; 39(11):1381-1386. PubMed ID: 31852637
[TBL] [Abstract][Full Text] [Related]
19. Genome-wide CRISPR screens for the identification of therapeutic targets for cancer treatment.
Xue VW; Wong SCC; Cho WCS
Expert Opin Ther Targets; 2020 Nov; 24(11):1147-1158. PubMed ID: 32893711
[TBL] [Abstract][Full Text] [Related]
20. Critical cancer vulnerabilities identified by unbiased CRISPR/Cas9 screens inform on efficient cancer Immunotherapy.
Potts MA; McDonald JA; Sutherland KD; Herold MJ
Eur J Immunol; 2020 Dec; 50(12):1871-1884. PubMed ID: 33202035
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
